Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9634)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 27, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World J Hepatol 2020; 12(8): 423-435 [PMID: 32952871 DOI: 10.4254/wjh.v12.i8.423] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i8/423.htm |
| Number | Citing Articles |
| 1 |
Yudian Zhang, Ying Liu, Wen Huo, Longfei He, Bowen Li, Hui Wang, Fanyin Meng, Chenggang Duan, Bingru Zhou, Jinbo Wu, Rong Chen, Juan Xing, Ying Wan. The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases. The American Journal of Pathology 2024; doi: 10.1016/j.ajpath.2024.02.006
|
| 2 |
Yuto Tanaka, Kenya Kamimura, Ryota Nakamura, Marina Ohkoshi-Yamada, Yohei Koseki, Takeshi Mizusawa, Satoshi Ikarashi, Kazunao Hayashi, Hiroki Sato, Akira Sakamaki, Junji Yokoyama, Shuji Terai. Usefulness of ultrasonography to assess the response to steroidal therapy for the rare case of type 2b immunoglobulin G4-related sclerosing cholangitis without pancreatitis: A case report. World Journal of Clinical Cases 2020; 8(22): 5821-5830 doi: 10.12998/wjcc.v8.i22.5821
|
| 3 |
Andreas Blesl, Vanessa Stadlbauer. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021; 13(3): 1018 doi: 10.3390/nu13031018
|
| 4 |
Ioana Ruxandra Mihai, Ciprian Rezus, Maria Alexandra Burlui, Anca Cardoneanu, Luana Andreea Macovei, Patricia Richter, Ioana Bratoiu, Elena Rezus. Autoimmune Liver Diseases and Rheumatoid Arthritis—Is There an Etiopathogenic Link?. International Journal of Molecular Sciences 2024; 25(7): 3848 doi: 10.3390/ijms25073848
|
| 5 |
Javier Martínez-García, Angie Molina, Gloria González-Aseguinolaza, Nicholas D. Weber, Cristian Smerdou. Gene Therapy for Acquired and Genetic Cholestasis. Biomedicines 2022; 10(6): 1238 doi: 10.3390/biomedicines10061238
|
| 6 |
Li-Ping You, Kai-Xia Wang, Jia-Cheng Lin, Xiao-Yu Ren, Yu Wei, Wen-Xuan Li, Yue-Qiu Gao, Xiao-Ni Kong, Xue-Hua Sun. Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation. Gene 2023; 851: 146973 doi: 10.1016/j.gene.2022.146973
|
| 7 |
Su Fang, Tianming Wang, Yuanyuan Li, Haoyu Xue, Juan Zou, Jingyi Cai, Rong Shi, Jiasheng Wu, Yueming Ma. Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway. International Journal of Biological Macromolecules 2022; 205: 23 doi: 10.1016/j.ijbiomac.2022.02.056
|
| 8 |
Josué Orozco-Aguilar, Felipe Simon, Claudio Cabello-Verrugio, Anwen Shao. Redox-Dependent Effects in the Physiopathological Role of Bile Acids. Oxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/4847941
|
| 9 |
Laura Molina, Kari Nejak-Bowen, Satdarshan P. Monga. Role of YAP1 Signaling in Biliary Development, Repair, and Disease. Seminars in Liver Disease 2022; 42(01): 017 doi: 10.1055/s-0041-1742277
|
| 10 |
T. E. Polunina. Cholestasis: algorithms for diagnosis and treatment. Academy of medicine and sports 2022; 2(4): 28 doi: 10.15829/2712-7567-2021-43
|
| 11 |
Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou. Bile Acids and Biliary Fibrosis. Cells 2023; 12(5): 792 doi: 10.3390/cells12050792
|
| 12 |
Yafei Xia, Shixin Yan, Yang Chang, Jiaoyang Yin, Hongyu Li, Shu Yan, Hua Li. Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1589388
|
| 13 |
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Ana L. Ordoñez-Vázquez. Current Therapies for Cholestatic Diseases. Biomedicines 2023; 11(6): 1713 doi: 10.3390/biomedicines11061713
|
| 14 |
E. D. Semivelichenko, A. S. Ivkina, A. V. Karavaeva, A. Yu. Grishina, E. I. Eletskaya, M. V. Krasnova, K. O. Sidorov, I. A. Titovich, D. Yu. Ivkin. Choleotropic Activity of <i>Cistus salviifolius</i> Extract. Drug development & registration 2023; doi: 10.33380/2305-2066-2023-12-4-1646
|
| 15 |
Nils P. Nickel, Gian M. Galura, Marc J. Zuckerman, M. Nawar Hakim, Haider Alkhateeb, Debabrata Mukherjee, Eric D. Austin, Gustavo A. Heresi. Liver abnormalities in pulmonary arterial hypertension. Pulmonary Circulation 2021; 11(4): 1 doi: 10.1177/20458940211054304
|
| 16 |
Jung-Yeon Kim, Hyo-Jeong Jang, Jaechan Leem, Gyun-Moo Kim. Protective Effects of Bee Venom-Derived Phospholipase A2 against Cholestatic Liver Disease in Mice. Biomedicines 2021; 9(8): 992 doi: 10.3390/biomedicines9080992
|
| 17 |
Chunlei Wei, Jing Qiu, Yuyi Wu, Ziqiang Chen, Ziwei Yu, Zecheng Huang, Ke Yang, Huiling Hu, Fang Liu. Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis). Journal of Ethnopharmacology 2022; 297: 115550 doi: 10.1016/j.jep.2022.115550
|
| 18 |
Poonam Yadav, Sumeet Kumar Singh, Sonu Rajput, Prince Allawadhi, Amit Khurana, Ralf Weiskirchen, Umashanker Navik. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges. Pharmacology & Therapeutics 2024; 253: 108563 doi: 10.1016/j.pharmthera.2023.108563
|
| 19 |
Ryan Philip Henry Shaw, Peter Kolyvas, Nathanlown Dang, Angela Hyon, Keith Bailey, Sayeepriyadarshini Anakk. Loss of Hepatic Small Heterodimer Partner Elevates Ileal Bile Acids and Alters Cell Cycle-related Genes in Male Mice. Endocrinology 2022; 163(6) doi: 10.1210/endocr/bqac052
|
| 20 |
Samantha Bartolone, Harvey N Mayrovitz. Intrahepatic Cholestasis of Pregnancy: Role of Baby’s Sex on Itch Severity and Bile Acid Levels. Cureus 2021; doi: 10.7759/cureus.14089
|
| 21 |
Huan Lan, Ying Zhang, Minqi Fan, Bingxin Wu, Caiyan Wang. Pregnane X receptor as a therapeutic target for cholestatic liver injury. Drug Metabolism Reviews 2023; 55(4): 371 doi: 10.1080/03602532.2023.2248680
|
| 22 |
Anca D. Petrescu, Sharon DeMorrow. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury. Cells 2021; 10(8): 1846 doi: 10.3390/cells10081846
|
| 23 |
Zhiqi Feng, Jiehao Xiang, Gang Sun, Hui Liu, Yanyan Wang, Xin Liu, Jin Feng, Qinglong Xu, Xiaoan Wen, Haoliang Yuan, Hongbin Sun, Liang Dai. Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases. Journal of Medicinal Chemistry 2023; 66(11): 7331 doi: 10.1021/acs.jmedchem.2c02123
|
| 24 |
Naser-Aldin Lashgari, Danial Khayatan, Nazanin Momeni Roudsari, Saeideh Momtaz, Ahmad Reza Dehpour, Amir Hossein Abdolghaffari. Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(3): 1433 doi: 10.1007/s00210-023-02684-2
|
| 25 |
Shiman Luo, Meilan Huang, Xiaohua Lu, Mingming Zhang, Huiling Xiong, Xiyue Tan, Xinyu Deng, Wenwen Zhang, Xiao Ma, Jinhao Zeng, Thomas Efferth. Optimized therapeutic potential of Yinchenhao decoction for cholestatic hepatitis by combined network meta-analysis and network pharmacology. Phytomedicine 2024; 129: 155573 doi: 10.1016/j.phymed.2024.155573
|
| 26 |
Soraya Salas-Silva, Jocelyn López-Ramirez, Jonatan Barrera-Chimal, Roberto Lazzarini-Lechuga, Arturo Simoni-Nieves, Verónica Souza, Roxana U. Miranda-Labra, Felipe Masso, Marcelo G. Roma, María Concepción Gutiérrez-Ruiz, Leticia Bucio-Ortiz, Luis E. Gomez-Quiroz. Hepatocyte growth factor reverses cholemic nephropathy associated with α-naphthylisothiocyanate-induced cholestasis in mice. Life Sciences 2022; 295: 120423 doi: 10.1016/j.lfs.2022.120423
|
| 27 |
Ioannis Evangelakos, Joerg Heeren, Esther Verkade, Folkert Kuipers. Role of bile acids in inflammatory liver diseases. Seminars in Immunopathology 2021; 43(4): 577 doi: 10.1007/s00281-021-00869-6
|
| 28 |
Jocelyn López-Ramirez, Roberto Lazzarini-Lechuga, Monserrat Gerardo-Ramírez, Alejandro Escobedo-Calvario, Lisette Chávez-Rodríguez, Soraya Salas-Silva, Natalia Nuño-Lámbarri, Felipe Massó, Verónica Souza-Arroyo, Roxana U. Miranda-Labra, María Concepción Gutiérrez-Ruiz, Luis E. Gomez-Quiroz, Leticia Bucio-Ortiz. The hepatocyte growth factor induces an anti-inflammatory and repairing response in the cholestasis-induced colon damage. Exploration of Digestive Diseases 2022; : 40 doi: 10.37349/edd.2022.00004
|
| 29 |
Nadia Waheed, Rehmana Waris, Maryam Naseer, Ayesha Razzaq, Sufyan Suleman, Asmat Ullah. Clinical exome sequencing reveals a novel pathogenic variant in KIF12 underlying cholestasis with highly variable phenotypes. Clinical Genetics 2024; 105(1): 106 doi: 10.1111/cge.14444
|
| 30 |
Jing Zeng, Jiangao Fan, Huiping Zhou. Bile acid-mediated signaling in cholestatic liver diseases. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01035-1
|
| 31 |
Samantha Sarcognato, Diana Sacchi, Federica Grillo, Nora Cazzagon, Luca Fabris, Massimiliano Cadamuro, Ivana Cataldo, Claudia Covelli, Alessandra Mangia, Maria Guido. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica 2021; 113(3): 170 doi: 10.32074/1591-951X-245
|